- Home
- SVRA vs OFIX Comparison
SVRA vs OFIX Comparison
Compare SVRA & OFIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVRA
- OFIX
- Stock Information
- Founded
- SVRA 2007
- OFIX 1987
- Country
- SVRA United States
- OFIX United States
- Employees
- SVRA N/A
- OFIX N/A
- Industry
- SVRA Biotechnology: Pharmaceutical Preparations
- OFIX Medical/Dental Instruments
- Sector
- SVRA Health Care
- OFIX Health Care
- Exchange
- SVRA Nasdaq
- OFIX Nasdaq
- Market Cap
- SVRA 527.2M
- OFIX 562.8M
- IPO Year
- SVRA N/A
- OFIX N/A
- Fundamental
- Price
- SVRA $3.61
- OFIX $14.75
- Analyst Decision
- SVRA Buy
- OFIX Strong Buy
- Analyst Count
- SVRA 8
- OFIX 5
- Target Price
- SVRA $6.63
- OFIX $21.50
- AVG Volume (30 Days)
- SVRA 1.7M
- OFIX 427.7K
- Earning Date
- SVRA 11-11-2025
- OFIX 11-06-2025
- Dividend Yield
- SVRA N/A
- OFIX N/A
- EPS Growth
- SVRA N/A
- OFIX N/A
- EPS
- SVRA N/A
- OFIX N/A
- Revenue
- SVRA N/A
- OFIX $809,030,000.00
- Revenue This Year
- SVRA N/A
- OFIX $3.86
- Revenue Next Year
- SVRA N/A
- OFIX $5.57
- P/E Ratio
- SVRA N/A
- OFIX N/A
- Revenue Growth
- SVRA N/A
- OFIX 4.84
- 52 Week Low
- SVRA $1.89
- OFIX $10.24
- 52 Week High
- SVRA $4.70
- OFIX $20.73
- Technical
- Relative Strength Index (RSI)
- SVRA 65.57
- OFIX 61.38
- Support Level
- SVRA $3.70
- OFIX $14.21
- Resistance Level
- SVRA $3.92
- OFIX $15.42
- Average True Range (ATR)
- SVRA 0.19
- OFIX 0.45
- MACD
- SVRA -0.01
- OFIX -0.11
- Stochastic Oscillator
- SVRA 59.10
- OFIX 44.63
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.
About OFIX Orthofix Medical Inc. (DE)
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries across the globe. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.